Key points from article :
Triple negative breast cancer is (TNBC) tend to exhibit aggressive behaviour and are more likely to spread to another part of the body, becoming incurable.
It is estimated that around 1,000 women each year in the UK are diagnosed with LAR TNBC – which accounts for around 2% of all breast cancers.
Researchers from Breast Cancer Now Toby Robins Research Centre at The Institute of Cancer Research (ICR) have identified a potential new treatment approach for some TNBCs after discovering them to be highly sensitive to new drugs called CDK4/6 inhibitors.
The study was published in the Clinical Cancer Research journal.
